La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Clínica Las Condes Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di Clínica Las Condes.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Healthcare crescita degli utili	27.7%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Jul 02

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Apr 30

Clínica Las Condes S.A.'s (SNSE:LAS CONDES) Business Is Yet to Catch Up With Its Share Price

Mar 28

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Jan 12

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Oct 24

Returns At Clínica Las Condes (SNSE:LAS CONDES) Are On The Way Up

Sep 27

Clínica Las Condes (SNSE:LAS CONDES) Is Experiencing Growth In Returns On Capital

Jun 21

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

May 19

Clínica Las Condes (SNSE:LAS CONDES) Is Doing The Right Things To Multiply Its Share Price

Aug 25

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Apr 20

Is Clínica Las Condes (SNSE:LAS CONDES) Using Too Much Debt?

Mar 10

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Oct 07

A Look At The Fair Value Of Clínica Las Condes S.A. (SNSE:LAS CONDES)

Aug 28

Does Clínica Las Condes (SNSE:LAS CONDES) Have A Healthy Balance Sheet?

May 31

Some Investors May Be Worried About Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Apr 16

A Look At Clínica Las Condes' (SNSE:LAS CONDES) Share Price Returns

Mar 12

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

Feb 05

Should You Be Impressed By Clínica Las Condes' (SNSE:LAS CONDES) Returns on Capital?

Jan 01

Clínica Las Condes'(SNSE:LAS CONDES) Share Price Is Down 36% Over The Past Five Years.

Nov 27

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché Clínica Las Condes non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

SNSE:LAS CONDES - Stime future degli analisti e dati finanziari passati (CLP Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2024	196,410	-2,977	2,729	5,996	N/A
3/31/2024	198,852	-2,146	8,110	12,433	N/A
12/31/2023	202,263	-3,401	7,991	13,589	N/A
9/30/2023	211,636	-3,614	10,542	18,272	N/A
6/30/2023	225,539	-1,240	26,211	35,639	N/A
3/31/2023	245,360	647	37,113	47,320	N/A
12/31/2022	259,992	4,047	37,205	49,213	N/A
9/30/2022	271,371	939	47,308	58,684	N/A
6/30/2022	279,943	8,916	36,052	46,376	N/A
3/31/2022	282,389	13,362	39,361	49,566	N/A
12/31/2021	276,854	18,417	29,900	37,601	N/A
9/30/2021	269,279	28,622	25,322	30,999	N/A
6/30/2021	248,857	19,437	18,136	22,066	N/A
3/31/2021	220,659	4,933	644	3,216	N/A
12/31/2020	212,266	-5,280	11,622	15,822	N/A
9/30/2020	202,808	-12,095	10,114	15,277	N/A
6/30/2020	209,306	-7,451	18,590	24,333	N/A
3/31/2020	224,860	1,750	22,405	29,031	N/A
12/31/2019	226,194	5,219	15,660	20,066	N/A
9/30/2019	227,965	8,375	25,815	29,195	N/A
6/30/2019	226,087	7,081	27,989	30,625	N/A
3/31/2019	224,119	4,778	13,992	16,806	N/A
12/31/2018	219,400	4,505	10,237	16,241	N/A
9/30/2018	206,418	-4,676	7,367	16,168	N/A
6/30/2018	203,297	-5,581	-4,785	8,939	N/A
3/31/2018	198,778	-5,100	N/A	24,030	N/A
12/31/2017	194,920	-10,346	N/A	25,341	N/A
9/30/2017	195,766	-9,252	N/A	21,246	N/A
6/30/2017	199,616	-5,559	N/A	8,245	N/A
3/31/2017	197,397	-3,258	N/A	3,253	N/A
12/31/2016	196,473	1,500	N/A	-7,191	N/A
9/30/2016	195,806	5,303	N/A	-20,704	N/A
6/30/2016	188,904	5,370	N/A	-4,569	N/A
3/31/2016	183,305	4,374	N/A	-5,973	N/A
12/31/2015	178,054	5,270	N/A	428	N/A
9/30/2015	174,007	7,929	N/A	9,025	N/A
6/30/2015	165,973	9,217	N/A	14,562	N/A
3/31/2015	160,604	12,272	N/A	15,747	N/A
12/31/2014	156,386	14,227	N/A	22,725	N/A
9/30/2014	151,772	17,275	N/A	24,894	N/A
6/30/2014	146,840	17,629	N/A	21,381	N/A
3/31/2014	142,837	18,135	N/A	23,327	N/A
12/31/2013	138,851	18,104	N/A	20,125	N/A
9/30/2013	136,462	17,669	N/A	20,475	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista LAS CONDES è superiore al tasso di risparmio ( 5.5% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di LAS CONDES cresceranno più velocemente del mercato CL

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di LAS CONDES cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di LAS CONDES cresceranno più rapidamente del mercato CL.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di LAS CONDES cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di LAS CONDES è previsto essere elevato tra 3 anni

Clínica Las Condes Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

New major risk - Financial position

Second quarter 2024 earnings released: CL$5.00 loss per share (vs CL$94.00 profit in 2Q 2023)

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Less than half of directors are independent

First quarter 2024 earnings released: EPS: CL$61.00 (vs CL$88.57 loss in 1Q 2023)

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Full year 2023 earnings released: CL$406 loss per share (vs CL$483 profit in FY 2022)

Clínica Las Condes S.A.'s (SNSE:LAS CONDES) Business Is Yet to Catch Up With Its Share Price

Now 22% overvalued after recent price rise

Now 22% overvalued after recent price rise

New major risk - Share price stability

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Third quarter 2023 earnings released: CL$419 loss per share (vs CL$136 loss in 3Q 2022)

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Returns At Clínica Las Condes (SNSE:LAS CONDES) Are On The Way Up

New major risk - Financial position

Second quarter 2023 earnings released: EPS: CL$94.00 (vs CL$319 in 2Q 2022)

New major risk - Financial position

Clínica Las Condes (SNSE:LAS CONDES) Is Experiencing Growth In Returns On Capital

Investor sentiment improves as stock rises 17%

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

Investor sentiment improves as stock rises 16%

Upcoming dividend of CL$145 per share at 1.3% yield

Investor sentiment improves as stock rises 21%

Full year 2022 earnings released: EPS: CL$483 (vs CL$2,199 in FY 2021)

Third quarter 2022 earnings released: CL$136 loss per share (vs CL$816 profit in 3Q 2021)

No independent directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CL$319 (vs CL$850 in 2Q 2021)

Clínica Las Condes (SNSE:LAS CONDES) Is Doing The Right Things To Multiply Its Share Price

First quarter 2022 earnings released: EPS: CL$317 (vs CL$921 in 1Q 2021)

Upcoming dividend of CL$660 per share

No independent directors

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Full year 2021 earnings released: EPS: CL$2,199 (vs CL$630 loss in FY 2020)

Is Clínica Las Condes (SNSE:LAS CONDES) Using Too Much Debt?

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Investor sentiment improved over the past week

A Look At The Fair Value Of Clínica Las Condes S.A. (SNSE:LAS CONDES)

Second quarter 2021 earnings released: EPS CL$850 (vs CL$882 loss in 2Q 2020)

Does Clínica Las Condes (SNSE:LAS CONDES) Have A Healthy Balance Sheet?

First quarter 2021 earnings released: EPS CL$921 (vs CL$298 loss in 1Q 2020)

Some Investors May Be Worried About Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

A Look At Clínica Las Condes' (SNSE:LAS CONDES) Share Price Returns

Full year 2020 earnings released: CL$630 loss per share (vs CL$623 profit in FY 2019)

New 90-day low: CL$22,499

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

New 90-day low: CL$23,820

Should You Be Impressed By Clínica Las Condes' (SNSE:LAS CONDES) Returns on Capital?

Third quarter 2020 earnings released: CL$281 loss per share

Clínica Las Condes'(SNSE:LAS CONDES) Share Price Is Down 36% Over The Past Five Years.

New 90-day low: CL$26,721

First half earnings released

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita